D
Kairos Pharma, Ltd. KAPA
$0.85 -$0.01-1.05% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Total Cash And Short-Term Investments 73.30% 14,347.62% 8,940.00% 1,267.74% 3,149.49%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 140.00% 417.65% 189.47% 375.00% -41.18%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -30.23% -- -- -- --
Total Current Assets 40.36% 12,634.21% 10,154.24% 4,027.72% 3,987.93%

Total Current Assets 40.36% 12,634.21% 10,154.24% 4,027.72% 3,987.93%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -61.07% -52.98% -46.78% -41.88% -37.91%
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- 145.22% 198.60% 185.68% --
Total Assets 61.19% 547.86% 716.56% 497.72% 427.85%

Total Accounts Payable -73.73% -76.70% -70.32% -58.68% -30.61%
Total Accrued Expenses -- -- -- -- --
Short-term Debt -- -- -- -- 3,450.00%
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -75.96% -77.52% -70.36% -58.75% -24.31%

Total Current Liabilities -75.96% -77.52% -70.36% -58.75% -24.31%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- 3,450.00%
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -75.96% -81.65% -76.13% -67.40% -40.73%

Common Stock & APIC 84.12% 323.22% 304.57% 228.76% 246.69%
Retained Earnings -64.61% -69.40% -54.20% -41.90% -53.81%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 130.01% 325.96% 397.04% 329.84% 277.90%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 130.01% 325.96% 397.04% 329.84% 277.90%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 130.01% 325.96% 397.04% 329.84% 277.90%